{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:24:00Z","timestamp":1781619840404,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12884-019-2321-8","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T13:03:42Z","timestamp":1560258222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prevalence and profile of adverse drug reactions in high-risk pregnancy: a cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Kathlen Dayanne Lopes","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Evelyn Medeiros","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"de Lima Pessoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Iasmin Vieira Cunha","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Gouveia","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rand Randall","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"2321_CR1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/rheumatology\/keu394","volume":"54","author":"MC Soh","year":"2015","unstructured":"Soh MC, Nelson-Piercy C. High-risk pregnancy and the rheumatologist. Rheumatology (Oxford). 2015;54:572\u201387. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/keu394\n                    \n                  .","journal-title":"Rheumatology (Oxford)"},{"key":"2321_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.26719\/2013.19.5.465","volume":"19","author":"N Bouafia","year":"2013","unstructured":"Bouafia N, Mahjoub M, Nouira A, Ben Aissa R, Sa\u00efdi H, Guedana N. Profil \u00e9pid\u00e9miologique des grossesses \u00e0 risque \u00e0 Sousse (Tunisie). East Mediterr Heal J. 2013;19:465\u201373.","journal-title":"East Mediterr Heal J"},{"key":"2321_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.5455\/2320-1770.ijrcog20140910","volume":"3","author":"S Jain","year":"2014","unstructured":"Jain S, Anand S, Aherwar R. High risk scoring for prediction of pregnancy outcome: a prospective study. Int J Reprod Contraception, Obstet Gynecol. 2014;3:516\u201322. \n                    https:\/\/doi.org\/10.5455\/2320-1770.ijrcog20140910\n                    \n                  .","journal-title":"Int J Reprod Contraception, Obstet Gynecol"},{"key":"2321_CR4","first-page":"3735","volume":"3","author":"E Kashani","year":"2012","unstructured":"Kashani E, Hassanzad A, Ameri MA. The rate of the prevalence of high-risk pregnancies and the results on pregnant mothers and the effect on parameters after the birth. Int J Pharm Sci Res. 2012;3:3735\u201341.","journal-title":"Int J Pharm Sci Res"},{"key":"2321_CR5","first-page":"212","volume":"3","author":"V Kumar","year":"2013","unstructured":"Kumar V, Kaur A, Chawla S, Malik M. Prevalence and correlates of high risk pregnancy in rural Haryana : a community based study. Int J App Basic Med Res. 2013;3:212\u20137.","journal-title":"Int J App Basic Med Res"},{"key":"2321_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/oalib.1103224","volume":"3","author":"KN Michel","year":"2016","unstructured":"Michel KN, Ilunga BC, Astrid KM, Blaise IK, Mariette KK, Pitchou KT, et al. Epidemiological profile of high-risk pregnancies in Lubumbashi: case of the provincial hospital Janson Sendwe. OALib. 2016;3:1\u20137. \n                    https:\/\/doi.org\/10.4236\/oalib.1103224\n                    \n                  .","journal-title":"OALib"},{"key":"2321_CR7","first-page":"27","volume-title":"Maternal and perinatal Rresults in high risk consultation at Ses hospital De Caldas, 2009\u20132011. Hacia la Promoci\u00f3n la Salud","author":"JE V\u00e9lez Arango","year":"2013","unstructured":"V\u00e9lez Arango JE, Herrera Morales LE, Arango G\u00f3mez F, Betancourt ALH, Duque JAP. Maternal and perinatal Rresults in high risk consultation at Ses hospital De Caldas, 2009\u20132011. Hacia la Promoci\u00f3n la Salud, vol. 18; 2013. p. 27\u201340."},{"key":"2321_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0152167","volume":"11","author":"PL Yeoh","year":"2016","unstructured":"Yeoh PL, Hornetz K, Dahlui M. Antenatal care utilisation and content between low-risk and high-risk pregnant women. PLoS One. 2016;11:1\u201318. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0152167\n                    \n                  .","journal-title":"PLoS One"},{"key":"2321_CR9","volume-title":"Trends in maternal mortality: 1990 to 2015: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division","author":"World Health Organization \u2013 WHO","year":"2015","unstructured":"World Health Organization \u2013 WHO. Trends in maternal mortality: 1990 to 2015: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. 2015. doi: 10."},{"key":"2321_CR10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/AOG.0000000000000746","volume":"125","author":"EK Main","year":"2015","unstructured":"Main EK, McCain CL, Morton CH, Holtby S, Lawton ES. Pregnancy-related mortality in California. Obstet Gynecol. 2015;125:938\u201347. \n                    https:\/\/doi.org\/10.1097\/AOG.0000000000000746\n                    \n                  .","journal-title":"Obstet Gynecol"},{"key":"2321_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1053\/j.semperi.2015.08.002","volume":"39","author":"M Ayad","year":"2015","unstructured":"Ayad M, Costantine MM. Epidemiology of medications use in pregnancy. Semin Perinatol. 2015;39:508\u201311. \n                    https:\/\/doi.org\/10.1053\/j.semperi.2015.08.002\n                    \n                  .","journal-title":"Semin Perinatol"},{"key":"2321_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40265-014-0187-7","volume":"74","author":"CM Brown","year":"2014","unstructured":"Brown CM, Garovic VD. Drug treatment of hypertension in pregnancy. Drugs. 2014;74:283\u201396. \n                    https:\/\/doi.org\/10.1007\/s40265-014-0187-7\n                    \n                  .","journal-title":"Drugs."},{"key":"2321_CR13","doi-asserted-by":"publisher","first-page":"457.e1","DOI":"10.1016\/j.ajog.2010.06.044","volume":"203","author":"JS Dhulkotia","year":"2010","unstructured":"Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010;203:457.e1\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ajog.2010.06.044\n                    \n                  .","journal-title":"Am J Obstet Gynecol"},{"key":"2321_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00228-016-2042-0","volume":"72","author":"J Smedberg","year":"2016","unstructured":"Smedberg J, Br\u00e5then M, Waka MS, Jacobsen AF, Gjerdalen G, Nordeng H. Medication use and drug-related problems among women at maternity wards \u2014 a cross-sectional study from two Norwegian hospitals. Eur J Clin Pharmacol. 2016;72:849\u201357. \n                    https:\/\/doi.org\/10.1007\/s00228-016-2042-0\n                    \n                  .","journal-title":"Eur J Clin Pharmacol"},{"key":"2321_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","volume":"39","author":"M Feghali","year":"2015","unstructured":"Feghali M, Venkataramanan R, Caritis S. Pharmacokinetics of drugs in pregnancy. Semin Perinatol. 2015;39:512\u20139. \n                    https:\/\/doi.org\/10.1053\/j.semperi.2015.08.003\n                    \n                  .","journal-title":"Semin Perinatol"},{"key":"2321_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2393-2-3","volume":"2","author":"DC Hern\u00e1ndez-Hern\u00e1ndez","year":"2002","unstructured":"Hern\u00e1ndez-Hern\u00e1ndez DC, Vargas-Rivera MJ, Nava-Ocampo AA, Palma-Aguirre JA, Sumano-L\u00f3pez H. Drug therapy and adverse drug reactions to terbutaline in obstetric patients: a prospective cohort study in hospitalized women. BMC Pregnancy Childbirth. 2002;2:1\u20136. \n                    https:\/\/doi.org\/10.1186\/1471-2393-2-3\n                    \n                  .","journal-title":"BMC Pregnancy Childbirth"},{"key":"2321_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jsps.2017.01.005","volume":"25","author":"AD De Oliveira-Filho","year":"2017","unstructured":"De Oliveira-Filho AD, Vieira AES, da Silva RC, Neves SJF, Gama TAB, Lima RV, Oliveira WR, de Gon\u00e7alves Dias JM. Adverse drug reactions in high-risk pregnant women: a prospective study. Saudi Pharm J. 2017;25:1073\u20137. \n                    https:\/\/doi.org\/10.1016\/j.jsps.2017.01.005\n                    \n                  .","journal-title":"Saudi Pharm J"},{"key":"2321_CR18","volume-title":"Requirements for adverse reaction reporting","author":"World Health Organization \u2013 WHO","year":"1975","unstructured":"World Health Organization \u2013 WHO. Requirements for adverse reaction reporting. Geneva: WHO; 1975."},{"key":"2321_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345. \n                    https:\/\/doi.org\/10.1038\/clpt.1981.154\n                    \n                  .","journal-title":"Clin Pharmacol Ther"},{"key":"2321_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2515\/therapie:2007067","volume":"62","author":"I Lacroix","year":"2007","unstructured":"Lacroix I, Cabou C, Montastruc J-L, Damase-Michel C. Effets ind\u00e9sirables des m\u00e9dicaments chez la femme enceinte. Therapie. 2007;62:455\u201360. \n                    https:\/\/doi.org\/10.2515\/therapie:2007067\n                    \n                  .","journal-title":"Therapie."},{"key":"2321_CR21","unstructured":"Scopolamine (2018). In Micromedex (Columbia Basin College Library ed.) [Electronic version]. Greenwood Village, CO: Truven Health Analytics. \n                    https:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/E2A350\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/E6A327\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.DoIntegratedSearch?SearchTerm=Scopolamine+Hydrobromide&fromInterSaltBase=true&false=null&false=null&=null#\n                    \n                  #. Accessed 15 Mar 2019."},{"key":"2321_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/jgs.14030","volume":"64","author":"BT Suehs","year":"2016","unstructured":"Suehs BT, Davis C, Franks B, Yuran TE, Ng D, Bradt J, et al. Effect of potentially inappropriate use of Antimuscarinic medications on healthcare use and cost in individuals with overactive bladder. J Am Geriatr Soc. 2016;64:779\u201387. \n                    https:\/\/doi.org\/10.1111\/jgs.14030\n                    \n                  .","journal-title":"J Am Geriatr Soc"},{"key":"2321_CR23","unstructured":"Methyldopa (2018). In Micromedex (Columbia Basin College Library ed.) [Electronic version]. Greenwood Village, CO: Truven Health Analytics. http:\/\/www-m.icromedexsolutions-\n                    com.ez18.periodicos.capes.gov.br\n                    \n                  \/micromedex2\/librarian\/PFD efaultActionId\/evidencexpert. DoIntegratedSearch# Accessed 15 March 2019."},{"key":"2321_CR24","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1345\/aph.1E642","volume":"39","author":"RS Evans","year":"2005","unstructured":"Evans RS, Lloyd JF, Stoddard GJ, Nebeker JR, Samore MH. Risk factors for adverse drug events: a 10-year analysis. Ann Pharmacother. 2005;39:1161\u20138. \n                    https:\/\/doi.org\/10.1345\/aph.1E642\n                    \n                  .","journal-title":"Ann Pharmacother"},{"key":"2321_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/CCM.0b013e318236f473","volume":"40","author":"SL Kane-Gill","year":"2012","unstructured":"Kane-Gill SL, Kirisci L, Verrico MM, Rothschild JM. Analysis of risk factors for adverse drug events in critically ill patients. Crit Care Med. 2012;40:823\u20138. \n                    https:\/\/doi.org\/10.1097\/CCM.0b013e318236f473\n                    \n                  .","journal-title":"Crit Care Med"},{"key":"2321_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00065","volume":"5","author":"MM Costantine","year":"2014","unstructured":"Costantine MM. Physiologic and pharmacokinetic changes in pregnancy. Front Pharmacol. 2014;5:65. \n                    https:\/\/doi.org\/10.3389\/fphar.2014.00065\n                    \n                  .","journal-title":"Front Pharmacol"},{"issue":"11","key":"2321_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002160","volume":"13","author":"G Pariente","year":"2016","unstructured":"Pariente G, Leibson T, Carls A, Adams-Webber T, Ito S, Koren G. Pregnancy-associated changes in pharmacokinetics: a systematic review. PLoS Med. 2016;13(11):e1002160. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1002160\n                    \n                  .","journal-title":"PLoS Med"},{"issue":"3","key":"2321_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11095-018-2352-2","volume":"35","author":"G Koren","year":"2018","unstructured":"Koren G, Pariente G. Pregnancy-associated changes in pharmacokinetics and their clinical implications. Pharm Res. 2018;35(3):61. \n                    https:\/\/doi.org\/10.1007\/s11095-018-2352-2\n                    \n                  .","journal-title":"Pharm Res"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2321-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-019-2321-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2321-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T23:18:09Z","timestamp":1591744689000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-019-2321-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2321"],"URL":"https:\/\/doi.org\/10.1186\/s12884-019-2321-8","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"assertion":[{"value":"20 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research Ethics Committee of Onofre Lopes University Hospital with number 508.201 and all study patients, or their legal representatives (first-degree relatives) when they presented impossibility to sign due to difficulty of movement, signed an Informed Consent Form. All consent procedures used were previously approved by the Institution\u2019s Research Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"199"}}